{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:30:14Z","timestamp":1789957814611,"version":"4.0.1"},"reference-count":120,"publisher":"Elsevier","isbn-type":[{"value":"9780128187708","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.irn.2018.10.007","type":"book-chapter","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T23:05:29Z","timestamp":1543446329000},"page":"59-93","source":"Crossref","is-referenced-by-count":12,"title":["Molecular Imaging of Dementia With Lewy Bodies"],"prefix":"10.1016","author":[{"given":"Oliver","family":"Cousins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyabah","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/0891988704267470","article-title":"Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?","volume":"17","author":"Aarsland","year":"2004","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nature Reviews. Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.parkreldis.2014.11.007","article-title":"Dopamine transporter imaging as a diagnostic tool for parkinsonism and related disorders in clinical practice","volume":"21","author":"Ba","year":"2015","journal-title":"Parkinsonism & Related Disorders"},{"issue":"9108","key":"10.1016\/bs.irn.2018.10.007_bb0025","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(05)78999-6","article-title":"Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease","volume":"351","author":"Ballard","year":"1998","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0030","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1041610215001039","article-title":"Is there a preference for PET or SPECT brain imaging in diagnosing dementia? The views of people with dementia, carers, and healthy controls","volume":"28","author":"Bamford","year":"2016","journal-title":"International Psychogeriatrics"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2018.10.007_bb0040","first-page":"630","article-title":"Initial clinical PET studies with the novel tau agent 18-F PI-2620 in Alzheimer's disease and controls","volume":"58","author":"Barret","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2018.10.007_bb0050","article-title":"In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer's disease dementia to young controls","author":"Betthauser","year":"2018","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.10.007_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymeth.2017.08.003","article-title":"Tau-imaging in neurodegeneration","volume":"130","author":"Bischof","year":"2017","journal-title":"Methods"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"Journal of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.007_bb0070","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0075","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2967\/jnumed.111.089946","article-title":"Cerebral glucose metabolic features of Parkinson disease and incident dementia: Longitudinal study","volume":"52","author":"Bohnen","year":"2011","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11910-017-0789-z","article-title":"Molecular imaging and updated diagnostic criteria in Lewy body dementias","volume":"17","author":"Bohnen","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0090","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiology of Aging"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.007_bb0095","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jns.2015.11.004","article-title":"123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias","volume":"359","author":"Brigo","year":"2015","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1148\/rg.343135065","article-title":"Brain PET in suspected dementia: Patterns of altered FDG metabolism","volume":"34","author":"Brown","year":"2014","journal-title":"Radiographics"},{"issue":"8","key":"10.1016\/bs.irn.2018.10.007_bb0105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","article-title":"The role of TREM2 in Alzheimer's disease and other neurodegenerative disorders","volume":"17","author":"Carmona","year":"2018","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1468-1331.2007.02001.x","article-title":"(99m)Tc-ethyl cysteinate dimer brain SPECT findings in early stage of dementia with Lewy bodies and Parkinson's disease patients: A correlation with neuropsychological tests","volume":"15","author":"Chang","year":"2008","journal-title":"European Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13244-011-0128-x","article-title":"Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseases","volume":"3","author":"Ching","year":"2012","journal-title":"Insights Imaging"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.007_bb0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-002-0778-5","article-title":"A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping","volume":"29","author":"Colloby","year":"2002","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroimage.2006.07.026","article-title":"In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia","volume":"33","author":"Colloby","year":"2006","journal-title":"NeuroImage"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/jcbfm.2013.2","article-title":"Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: Utility in differential diagnosis","volume":"33","author":"Colloby","year":"2013","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0891988709355272","article-title":"Covariance 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: Utility in differential diagnosis","volume":"23","author":"Colloby","year":"2010","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0140","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/gps.4036","article-title":"A comparison of FDG-PET and blood flow SPECT in the diagnosis of neurodegenerative dementias: A systematic review","volume":"29","author":"Davison","year":"2014","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.007_bb0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/mds.27403","article-title":"Clinical and imaging correlates of amyloid deposition in dementia with Lewy bodies","volume":"33","author":"Donaghy","year":"2018","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0150","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JPD-130247","article-title":"\u03b1-Synuclein imaging: A critical need for Parkinson's disease research","volume":"3","author":"Eberling","year":"2013","journal-title":"Journal of Parkinson's Disease"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/npp.2012.255","article-title":"Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia","volume":"38","author":"Edison","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"10.1016\/bs.irn.2018.10.007_bb0160","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jalz.2014.06.016","article-title":"Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia","volume":"11","author":"Fan","year":"2015","journal-title":"Alzheimers Dementia"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s11682-015-9434-0","article-title":"The relationship between hallucinations and FDG-PET in dementia with Lewy bodies","volume":"10","author":"Firbank","year":"2016","journal-title":"Brain Imaging and Behavior"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer's disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40336-015-0104-4","article-title":"Imaging amyloidopathy in Parkinson disease and parkinsonian dementia syndromes","volume":"3","author":"Frey","year":"2015","journal-title":"Clinical and Translational Imaging"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0185","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/ana.20088","article-title":"Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease","volume":"55","author":"Gilman","year":"2004","journal-title":"Annals of Neurology"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2018.10.007_bb0190","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.expneurol.2004.06.017","article-title":"Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing","volume":"191","author":"Gilman","year":"2005","journal-title":"Experimental Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2018.10.007_bb0195","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","article-title":"Orthostatic hypotension from sympathetic denervation in Parkinson's disease","volume":"58","author":"Goldstein","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0200","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau positron emission tomographic imaging in the Lewy body diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/WNL.0b013e31827b1a07","article-title":"Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia","volume":"80","author":"Gomperts","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2018.10.007_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1212\/WNL.0000000000000734","article-title":"Dementia with Lewy bodies: Basis of cingulate island sign","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer's disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0220","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/mds.26961","article-title":"In vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography","volume":"32","author":"Hansen","year":"2017","journal-title":"Movement Disorders"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.007_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2006.07.007","article-title":"Differentiation of dementia with Lewy bodies from Alzheimer's disease using mini-mental state examination and brain perfusion SPECT","volume":"250","author":"Hanyu","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0230","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","article-title":"The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0235","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7342","article-title":"Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies","volume":"162","author":"Higuchi","year":"2000","journal-title":"Experimental Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0240","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0245","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.parkreldis.2013.05.010","article-title":"Neuropathology of dementia in a large cohort of patients with Parkinson's disease","volume":"19","author":"Horvath","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0250","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.55.10.1575","article-title":"18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies","volume":"55","author":"Hu","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0255","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","article-title":"In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease","volume":"19","author":"Iannaccone","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0260","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12149-016-1076-9","article-title":"Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies","volume":"30","author":"Iizuka","year":"2016","journal-title":"Annals of Nuclear Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.007_bb0265","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12149-017-1181-4","article-title":"Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT","volume":"31","author":"Imabayashi","year":"2017","journal-title":"Annals of Nuclear Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2018.10.007_bb0270","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/00001756-199906230-00020","article-title":"Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB)","volume":"10","author":"Imamura","year":"1999","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.007_bb0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3940(97)00713-1","article-title":"Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: A comparative study using positron emission tomography","volume":"235","author":"Imamura","year":"1997","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12149-014-0911-0","article-title":"Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition","volume":"29","author":"Ishii","year":"2015","journal-title":"Annals of Nuclear Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0285","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.51.1.125","article-title":"Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease","volume":"51","author":"Ishii","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-018-1016-8","article-title":"Are dementia with Lewy bodies and Parkinson's disease dementia the same disease","volume":"16","author":"Jellinger","year":"2018","journal-title":"BMC Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0295","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and \u03b2-amyloid positron emission tomography imaging in dementia with Lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2018.10.007_bb0300","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2011.09.024","article-title":"Multimodality imaging characteristics of dementia with Lewy bodies","volume":"33","author":"Kantarci","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.007_bb0305","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00259-009-1266-y","article-title":"EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2","volume":"36","author":"Kapucu","year":"2009","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0310","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0315","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Annals of Neurology"},{"issue":"1 Suppl 1","key":"10.1016\/bs.irn.2018.10.007_bb0320","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jalz.2007.11.016","article-title":"Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography","volume":"4","author":"Koeppe","year":"2008","journal-title":"Alzheimers Dementia"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0325","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of \u03b1-synuclein and A\u03b2 in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2018.10.007_bb0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s40336-016-0217-4","article-title":"Current status of the development of PET radiotracers for imaging alpha synuclein aggregates in Lewy bodies and Lewy neurites","volume":"5","author":"Kotzbauer","year":"2017","journal-title":"Clinical and Translational Imaging"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0335","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2967\/jnumed.109.065870","article-title":"The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies","volume":"50","author":"Lim","year":"2009","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0340","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.007_bb0345","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","article-title":"Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD","volume":"56","author":"Lobotesis","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0350","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.55.1.132","article-title":"Activated microglia in dementia with Lewy bodies","volume":"55","author":"Mackenzie","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.10.007_bb0355","article-title":"Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies","volume":"1","author":"McCleery","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0360","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"9247","key":"10.1016\/bs.irn.2018.10.007_bb0365","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"issue":"6855","key":"10.1016\/bs.irn.2018.10.007_bb0370","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/bmj.305.6855.673","article-title":"Neuroleptic sensitivity in patients with senile dementia of Lewy body type","volume":"305","author":"McKeith","year":"1992","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0375","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: A phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0380","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dementia"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0385","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","article-title":"Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation","volume":"50","author":"Minoshima","year":"2001","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0390","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/153331750401900309","article-title":"Clinicopathological concordance of dementia diagnoses by community versus tertiary care clinicians","volume":"19","author":"Mok","year":"2004","journal-title":"American Journal of Alzheimer's Disease and Other Dementias"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0395","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jnnp-2012-302577","article-title":"Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT","volume":"83","author":"Morgan","year":"2012","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0400","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias","volume":"49","author":"Mosconi","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0405","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1017\/S1041610214002555","article-title":"Molecular imaging biomarkers for dementia with Lewy bodies: An update","volume":"27","author":"Mukaetova-Ladinska","year":"2015","journal-title":"International Psychogeriatrics"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0410","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuroimage.2008.01.010","article-title":"Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations","volume":"40","author":"O'Brien","year":"2008","journal-title":"NeuroImage"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.007_bb0415","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2967\/jnumed.114.143347","article-title":"18F-FDG PET and perfusion SPECT in the diagnosis of Alzheimer and Lewy body dementias","volume":"55","author":"O'Brien","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"issue":"20","key":"10.1016\/bs.irn.2018.10.007_bb0420","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1212\/01.wnl.0000435553.67953.81","article-title":"Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies","volume":"81","author":"Oda","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","article-title":"Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease","volume":"17","author":"Orimo","year":"2007","journal-title":"Brain Pathology"},{"key":"10.1016\/bs.irn.2018.10.007_bb0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.arr.2016.01.001","article-title":"(123)I-meta-iodobenzylguanidine (MIBG) cardiac scintigraphy in \u03b1-synucleinopathies","volume":"30","author":"Orimo","year":"2016","journal-title":"Ageing Research Reviews"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0435","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00259-002-0919-x","article-title":"Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies","volume":"29","author":"Pasquier","year":"2002","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0440","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000132084","article-title":"Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations","volume":"25","author":"Perneczky","year":"2008","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.007_bb0445","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.26191","article-title":"Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.007_bb0450","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","article-title":"Neuroimaging in Parkinson disease: From research setting to clinical practice","volume":"10","author":"Politis","year":"2014","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/bs.irn.2018.10.007_bb0455","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: Evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Molecular Neurodegeneration"},{"issue":"14","key":"10.1016\/bs.irn.2018.10.007_bb0460","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.22702","article-title":"Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I-FP-CIT SPECT study","volume":"24","author":"Roselli","year":"2009","journal-title":"Movement Disorders"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.007_bb0465","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.parkreldis.2009.05.012","article-title":"\u201cParkinson-dementia\u201d diseases: A comparison by double tracer SPECT studies","volume":"15","author":"Rossi","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"issue":"20","key":"10.1016\/bs.irn.2018.10.007_bb0470","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.007_bb0475","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","article-title":"Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders","volume":"9","author":"Rupprecht","year":"2010","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.007_bb0480","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease","volume":"141","author":"Schulz","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0485","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.26369","article-title":"Striatal and cortical \u03b2-amyloidopathy and cognition in Parkinson's disease","volume":"31","author":"Shah","year":"2016","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0490","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archneur.57.6.817","article-title":"Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies","volume":"57","author":"Shepherd","year":"2000","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0495","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0500","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/gps.4338","article-title":"Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity\u2014A [11C]MP4A PET study","volume":"30","author":"Shimada","year":"2015","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0505","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000085070","article-title":"Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT","volume":"20","author":"Shimizu","year":"2005","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.007_bb0510","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12149-017-1166-3","article-title":"Correlation between clinical symptoms and striatal DAT uptake in patients with DLB","volume":"31","author":"Shimizu","year":"2017","journal-title":"Annals of Nuclear Medicine"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.007_bb0515","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ggi.12794","article-title":"Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?","volume":"17","author":"Shimizu","year":"2017","journal-title":"Geriatrics & Gerontology International"},{"key":"10.1016\/bs.irn.2018.10.007_bb0520","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2377-14-79","article-title":"PET imaging of amyloid with florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders","volume":"14","author":"Siderowf","year":"2014","journal-title":"BMC Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.007_bb0525","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mds.26327","article-title":"Loss of dopamine transporter binding and clinical symptoms in dementia with Lewy bodies","volume":"31","author":"Siepel","year":"2016","journal-title":"Movement Disorders"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.007_bb0530","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2005.08.011","article-title":"Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: Comparison between dementia with Lewy bodies and Parkinson's disease","volume":"240","author":"Suzuki","year":"2006","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0535","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","article-title":"Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB","volume":"88","author":"Thomas","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0540","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1552-6569.2010.00532.x","article-title":"Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: A systematic review and a meta-analysis","volume":"22","author":"Treglia","year":"2012","journal-title":"Journal of Neuroimaging"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0545","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: A systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychological Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.007_bb0550","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archneurol.2011.142","article-title":"In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease","volume":"68","author":"Villemagne","year":"2011","journal-title":"Archives of Neurology"},{"issue":"1\u20134","key":"10.1016\/bs.irn.2018.10.007_bb0555","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000334535","article-title":"Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging","volume":"10","author":"Villemagne","year":"2012","journal-title":"Neurodegenerative Diseases"},{"issue":"10004","key":"10.1016\/bs.irn.2018.10.007_bb0560","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/bs.irn.2018.10.007_bb0565","doi-asserted-by":"crossref","first-page":"S754","DOI":"10.1002\/mds.22591","article-title":"Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies","volume":"24","author":"Walker","year":"2009","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0570","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse","year":"1983","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.007_bb0575","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2967\/jnumed.116.179903","article-title":"F-FDG PET in posterior cortical atrophy and dementia with Lewy bodies","volume":"58","author":"Whitwell","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.007_bb0580","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.007_bb0585","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaneurol.2017.3713","article-title":"Associations between tau, \u03b2-amyloid, and cognition in Parkinson disease","volume":"75","author":"Winer","year":"2018","journal-title":"JAMA Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.007_bb0590","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jalz.2012.11.008","article-title":"[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease","volume":"9","author":"Xia","year":"2013","journal-title":"Alzheimers Dementia"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.007_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120540","article-title":"Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: A multicenter study","volume":"10","author":"Yoshita","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2018.10.007_bb0600","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-018-8892-x","article-title":"Neuroimaging in Lewy body dementia","author":"Yousaf","year":"2018","journal-title":"Journal of Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.007_bb0605","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2967\/jnumed.112.114025","article-title":"Striatal dopamine transporter binding does not correlate with clinical severity in dementia with Lewy bodies","volume":"54","author":"Ziebell","year":"2013","journal-title":"Journal of Nuclear Medicine"}],"container-title":["International Review of Neurobiology","Imaging in Movement Disorders: Imaging in Non-Parkinsonian Movement Disorders and Dementias, Part 2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218301363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218301363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T21:33:53Z","timestamp":1720820033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774218301363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128187708"],"references-count":120,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2018.10.007","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}